FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087935029> ?p ?o ?g. }

• W3087935029 endingPage "353" @default.
• W3087935029 startingPage "343" @default.
• W3087935029 abstract "Gastric intestinal metaplasia is a pre-cancerous condition associated with multiple factors.We evaluated whether cumulative proton pump inhibitor dose is associated with the diagnosis of gastric intestinal metaplasia while controlling for multiple variables.We retrospectively identified patients who underwent upper endoscopy with gastric biopsy between 2005 and 2014. Covariate data retrieved included age, sex, ethnicity, smoking status, Helicobacter pylori status (based on clarithromycin-amoxicillin-proton pump inhibitor issued), cumulative proton pump inhibitor issued within 10 years (quartiles [PPI-Q1-4 ] of daily drug dose), anti-parietal cell antibodies, body mass index and comorbidity index.Of the 14,147 included patients (median age 63.4 years; women 54.4%; Helicobacter pylori-positive 29.0%), 1244 (8.8%) had gastric intestinal metaplasia. Increasing age, Helicobacter pylori infection, smoking, anti-parietal cell antibodies and proton pump inhibitor use were all associated with the diagnosis of gastric intestinal metaplasia. Upper quartiles of cumulative proton pump inhibitor doses (PPI-Q4 and PPI-Q3 vs. PPI-Q1 ) were associated with the diagnosis of gastric intestinal metaplasia: adjusted odds ratios 1.32 (95% confidence interval [CI] 1.111.57) and 1.27 (95% CI 1.07-1.52), respectively, for the whole cohort (Ptotal 0.007, Ptrend 0.013), 1.69 (95% CI 1.23-2.33) and 1.40 (95% CI 1.04-1.89), respectively, for Helicobacter pylori-positive patients (Ptotal 0.004, Ptrend 0.005) and 1.21 (95% CI 0.98-1.49) and 1.20 (95% CI 0.96-1.49), respectively, for Helicobacter pylori-negative patients (Ptotal 0.288, Ptrend 0.018). Upper quartiles of proton pump inhibitor dose were associated with a 5-10-fold increased risk of low-grade dysplasia.Among Helicobacter pylori-positive patients, proton pump inhibitor use appears to be associated with a dose-dependent increased likelihood of gastric intestinal metaplasia." @default.
• W3087935029 created "2020-10-01" @default.
• W3087935029 creator A5003162585 @default.
• W3087935029 creator A5004315487 @default.
• W3087935029 creator A5008488023 @default.
• W3087935029 creator A5017345957 @default.
• W3087935029 creator A5024366355 @default.
• W3087935029 creator A5029273084 @default.
• W3087935029 creator A5036334249 @default.
• W3087935029 creator A5040780841 @default.
• W3087935029 creator A5043867784 @default.
• W3087935029 creator A5055862445 @default.
• W3087935029 creator A5060867806 @default.
• W3087935029 date "2021-03-18" @default.
• W3087935029 modified "2023-10-15" @default.
• W3087935029 title "Dose‐dependent association of proton pump inhibitors use with gastric intestinal metaplasia among <i>Helicobacter pylori‐positive</i> patients" @default.
• W3087935029 cites W1570316968 @default.
• W3087935029 cites W1927285981 @default.
• W3087935029 cites W2069367602 @default.
• W3087935029 cites W2078102349 @default.
• W3087935029 cites W2111942462 @default.
• W3087935029 cites W2117885857 @default.
• W3087935029 cites W2154692607 @default.
• W3087935029 cites W2351668292 @default.
• W3087935029 cites W2394991965 @default.
• W3087935029 cites W2395736350 @default.
• W3087935029 cites W2527848138 @default.
• W3087935029 cites W2601779407 @default.
• W3087935029 cites W2620581837 @default.
• W3087935029 cites W2766436834 @default.
• W3087935029 cites W2767066701 @default.
• W3087935029 cites W2790102399 @default.
• W3087935029 cites W2800194289 @default.
• W3087935029 cites W2801893886 @default.
• W3087935029 cites W2914433551 @default.
• W3087935029 cites W2921353582 @default.
• W3087935029 cites W2944254627 @default.
• W3087935029 cites W2952732266 @default.
• W3087935029 cites W2964490743 @default.
• W3087935029 cites W2968235104 @default.
• W3087935029 cites W2981032494 @default.
• W3087935029 cites W2992576621 @default.
• W3087935029 cites W2992664796 @default.
• W3087935029 cites W2998428521 @default.
• W3087935029 cites W2999307306 @default.
• W3087935029 cites W2999810038 @default.
• W3087935029 cites W74755816 @default.
• W3087935029 doi "https://doi.org/10.1177/2050640620951403" @default.
• W3087935029 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8259238" @default.
• W3087935029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32962566" @default.
• W3087935029 hasPublicationYear "2021" @default.
• W3087935029 type Work @default.
• W3087935029 sameAs 3087935029 @default.
• W3087935029 citedByCount "1" @default.
• W3087935029 countsByYear W30879350292021 @default.
• W3087935029 crossrefType "journal-article" @default.
• W3087935029 hasAuthorship W3087935029A5003162585 @default.
• W3087935029 hasAuthorship W3087935029A5004315487 @default.
• W3087935029 hasAuthorship W3087935029A5008488023 @default.
• W3087935029 hasAuthorship W3087935029A5017345957 @default.
• W3087935029 hasAuthorship W3087935029A5024366355 @default.
• W3087935029 hasAuthorship W3087935029A5029273084 @default.
• W3087935029 hasAuthorship W3087935029A5036334249 @default.
• W3087935029 hasAuthorship W3087935029A5040780841 @default.
• W3087935029 hasAuthorship W3087935029A5043867784 @default.
• W3087935029 hasAuthorship W3087935029A5055862445 @default.
• W3087935029 hasAuthorship W3087935029A5060867806 @default.
• W3087935029 hasBestOaLocation W30879350291 @default.
• W3087935029 hasConcept C126322002 @default.
• W3087935029 hasConcept C156957248 @default.
• W3087935029 hasConcept C2776409635 @default.
• W3087935029 hasConcept C2776497702 @default.
• W3087935029 hasConcept C2778204628 @default.
• W3087935029 hasConcept C2778677798 @default.
• W3087935029 hasConcept C2780342937 @default.
• W3087935029 hasConcept C2781025758 @default.
• W3087935029 hasConcept C44249647 @default.
• W3087935029 hasConcept C71924100 @default.
• W3087935029 hasConcept C90924648 @default.
• W3087935029 hasConceptScore W3087935029C126322002 @default.
• W3087935029 hasConceptScore W3087935029C156957248 @default.
• W3087935029 hasConceptScore W3087935029C2776409635 @default.
• W3087935029 hasConceptScore W3087935029C2776497702 @default.
• W3087935029 hasConceptScore W3087935029C2778204628 @default.
• W3087935029 hasConceptScore W3087935029C2778677798 @default.
• W3087935029 hasConceptScore W3087935029C2780342937 @default.
• W3087935029 hasConceptScore W3087935029C2781025758 @default.
• W3087935029 hasConceptScore W3087935029C44249647 @default.
• W3087935029 hasConceptScore W3087935029C71924100 @default.
• W3087935029 hasConceptScore W3087935029C90924648 @default.
• W3087935029 hasIssue "3" @default.
• W3087935029 hasLocation W30879350291 @default.
• W3087935029 hasLocation W30879350292 @default.
• W3087935029 hasLocation W30879350293 @default.
• W3087935029 hasOpenAccess W3087935029 @default.
• W3087935029 hasPrimaryLocation W30879350291 @default.
• W3087935029 hasRelatedWork W119703562 @default.
• W3087935029 hasRelatedWork W1831821143 @default.

• next